Latest and Greatest in Practical Application of CV Outcomes for T2D Drugs
Diabetes is among the major risk factors for cardiovascular disease (CVD), which takes the lives of approximately 2100 people each day in the United States.[Mozaffarian 2015] CVD is the major cause of morbidity and mortality for patients with diabetes, as common coexisting conditions such as hypertension, obesity, and dyslipidemia increase cardiovascular (CV) risk.[ADA 2015; Go 2013; Halter 2014] Compared with nondiabetic individuals, the incidences of myocardial infarction (MI) and stroke are increased 2- to 3-fold in patients with type 2 diabetes (T2D).[Ferrannini 2015]
The goal of this activity is to provide participants with an increased awareness of new data related to the effect of glucose-lowering drugs on cardiovascular disease, specifically, hospitalizations for heart failure, in patients with T2D.
Please Note: this course is housed on Medscape. Upon selecting 'Click Here to Enroll,' you will be redirected to Medscape to compete the activity.